Difference between revisions of "Template:Antidepressants"
Jump to navigation
Jump to search
({{Navbox with collapsible sections}} to handle this large template -- smaller dots (like other templates) that are linewrap-aware) |
|||
| Line 1: | Line 1: | ||
| − | {{Navbox | + | {{Navbox with collapsible sections |
| name = Antidepressants | | name = Antidepressants | ||
| title = [[Antidepressant]]s ([[ATC_code_N06#N06A_Antidepressants|N06A]]) | | title = [[Antidepressant]]s ([[ATC_code_N06#N06A_Antidepressants|N06A]]) | ||
| groupstyle = background: LemonChiffon | | groupstyle = background: LemonChiffon | ||
| − | | group1 = [[Reuptake inhibitor|RIs | + | | group1 = [[Reuptake inhibitor]]s |
| − | | list1 = {{Navbox subgroup | + | | abbr1 = RIs |
| − | | groupstyle = background: LemonChiffon | + | | list1 = |
| + | {{Navbox subgroup | ||
| + | |groupstyle = background:LemonChiffon; | ||
| + | |group1 = [[Selective serotonin reuptake inhibitor|SSRI]]s | ||
| + | |list1 = <div> | ||
| + | [[Fluoxetine]]{{smallsup|1}}{{·}} [[Alaproclate]]{{·}} [[Citalopram]]{{·}} [[Dapoxetine]]{{·}} [[Desmethylcitalopram]]{{·}} [[Desmethylsertraline]]{{·}} [[Escitalopram]]{{·}} [[Femoxetine]]{{·}} [[Fluvoxamine]]{{·}} [[Indalpine]]{{·}} [[Litoxetine]]{{·}} [[Lubazodone]]{{·}} [[Norfluoxetine]]{{·}} [[Paroxetine]]{{·}} [[Sertraline]]{{·}} [[Vilazodone]]{{·}} [[Viqualine]]{{·}} [[Zimelidine]]{{smallsup|2}} | ||
| + | </div> | ||
| + | |group2 = [[Serotonin-norepinephrine reuptake inhibitor|SNRI]]s | ||
| + | |list2 = <div> | ||
| + | [[Clovoxamine]]{{·}} [[Duloxetine]]{{·}} [[Milnacipran]]{{·}} [[Sibutramine]]{{·}} [[Tramadol]]{{·}} [[Venlafaxine]] ([[Desvenlafaxine]]){{·}} [[Bicifadine]]{{smallsup|3}} | ||
| + | </div> | ||
| + | |group3 = [[Norepinephrine reuptake inhibitor|NRI]]s | ||
| + | |list3 = <div> | ||
| + | [[Atomoxetine]] / [[Tomoxetine]]{{·}} [[Binedaline]]{{·}} [[Ciclazindol]]{{·}} [[Mazindol]]{{·}} [[Nisoxetine]]{{·}} [[Reboxetine]]{{·}} [[Tandamine]]{{·}} [[Tapentadol]]{{·}} [[Viloxazine]] | ||
| + | </div> | ||
| + | |group4 = [[Norepinephrine-dopamine reuptake inhibitor|NDRI]]s | ||
| + | |list4 = <div> | ||
| + | [[Amineptine]]{{smallsup|2}}{{·}} [[Bupropion]]{{·}} [[Cilobamine]]{{·}} [[Manifaxine]]{{·}} [[Methylphenidate]]{{·}} [[Nomifensine]]{{smallsup|2}}{{·}} [[Radafaxine]] | ||
| + | </div> | ||
| + | |group5 = [[Dopamine reuptake inhibitor|DRIs]] | ||
| + | |list5 = <div> | ||
| + | [[Medifoxamine]]{{smallsup|2}}{{·}} [[Vanoxerine]]{{smallsup|4}} | ||
| + | </div> | ||
| + | |group6 = [[Serotonin-noradrenaline-dopamine_reuptake_inhibitor|SNDRI]]s | ||
| + | |list6 = <div> | ||
| + | [[Tesofensine]]{{smallsup|3}}{{·}} [[Brasofensine]]{{smallsup|4}}{{·}} [[BTS-74,398]]{{·}} [[Cocaine]]{{·}} [[Diclofensine]]{{smallsup|4}}{{·}} [[DOV-102,677]]{{·}} [[DOV-21,947]]{{·}} [[DOV-216,303]]{{·}} [[JNJ-7925476|JNJ-7,925,476]]{{·}} [[NS-2359]]{{·}} [[PRC200-SS]]{{·}} [[SEP-225,289]]{{·}} [[SEP-227,162]] | ||
| + | </div> | ||
| + | }} | ||
| − | | | + | | group2 = [[Selective serotonin reuptake enhancer|Selective serotonin reuptake enhancers (SSREs)]] |
| − | | | + | | abbr2 = SSREs |
| + | | list2 = <div> | ||
| + | [[Tianeptine]] | ||
| + | </div> | ||
| − | | | + | | group3 = [[Norepinephrine-dopamine releasing agent|Norepinephrine-dopamine releasing agent (NDRAs)]] |
| − | | | + | | abbr3 = NDRAs |
| + | | list3 = <div> | ||
| + | [[Amphetamine]]{{·}} [[Befuraline]]{{·}} [[Lisdexamfetamine]]{{·}} [[Methamphetamine]]{{·}} [[Oxaflozane]]{{·}} [[Phenethylamine]]{{·}} [[Piberaline]] | ||
| + | </div> | ||
| − | | | + | | group4 = [[Tricyclic antidepressant|Tricyclic antidepressants (TCAs)]] |
| − | | | + | | abbr4 = TCAs |
| + | | list4 = | ||
| + | {{Navbox subgroup | ||
| + | |groupstyle = background:LemonChiffon; | ||
| + | |group1 = Serotonin | ||
| + | |list1 = <div> | ||
| + | [[Cianopramine]]{{·}} [[Clomipramine]] | ||
| + | </div> | ||
| + | |group2 = Norepinephrine | ||
| + | |list2 = <div> | ||
| + | [[Amoxapine]]{{·}} [[Butriptyline]]{{·}} [[Desipramine]]/[[Lofepramine]]{{·}} [[Dibenzepin]]{{·}} [[Dosulepin hydrochloride|Dosulepin]]{{·}} [[Doxepin]]{{·}} [[Iprindole]]{{·}} [[Melitracen]]{{·}} [[Nitroxazepine]]{{·}} [[Nortriptyline]]{{·}} [[Protriptyline]]{{·}} [[Trimipramine]] | ||
| + | </div> | ||
| + | |group3 = {{line-height|1.2em|Serotonin and<br/>norepinephrine}} | ||
| + | |list3 = <div> | ||
| + | [[Amitriptyline]]{{smallsup|1}}{{·}} [[Imipramine]] | ||
| + | </div> | ||
| + | }} | ||
| − | | | + | | group5 = [[Monoamine oxidase inhibitor|Monoamine oxidase inhibitors (MAOIs)]] |
| − | | | + | | abbr5 = MAOIs |
| + | | list5 = | ||
| + | {{Navbox subgroup | ||
| + | |groupstyle = background:LemonChiffon; | ||
| + | |group1 = Nonselective | ||
| + | |list1 = <div> | ||
| + | [[Benmoxin]]{{·}} [[Iproclozide]]{{·}} [[Iproniazid]]{{·}} [[Isocarboxazid]]{{·}} [[Mebanazine]]{{·}} [[Metfendrazine]]{{·}} [[Nialamide]]{{·}} [[Phenelzine]]{{·}} [[Pheniprazine]]{{·}} [[Phenoxypropazine]]{{·}} [[Pivalylbenzhydrazine]]{{·}} [[Safrazine]]{{·}} [[Tranylcypromine]] | ||
| + | </div> | ||
| + | |group2 = [[Monoamine oxidase A|MAO-A]] selective | ||
| + | |list2 = <div> | ||
| + | [[Clorgyline]]{{·}} | ||
| + | [[Reversible inhibitor of monoamine oxidase A|RIMA]]s ([[Befloxatone]]{{·}} [[Brofaromine]]{{·}} [[Cimoxatone]]{{·}} | ||
| + | [[Harmala alkaloid]]s <small>([[Harmine]]{{•}} [[Harmaline]]{{•}} [[Tetrahydroharmine]]{{•}} etc)</small>{{·}} | ||
| + | [[Metralindole]]{{·}} [[Minaprine]]{{·}} [[Moclobemide]]{{·}} [[Pirlindole]]{{·}} [[Toloxatone]]{{·}} [[Tyrima]]) | ||
| + | </div> | ||
| + | |group3 = [[Monoamine oxidase B|MAO-B]] selective | ||
| + | |list3 = <div> | ||
| + | [[Ladostigil]]{{·}} [[Lazabemide]]{{·}} [[Pargyline]]{{·}} [[Rasagiline]]{{·}} [[Selegiline]] | ||
| + | </div> | ||
| + | }} | ||
| − | | group5 = [[Dopamine | + | | group6 = Direct [[Ligand (biochemistry)|receptor ligand]]s |
| − | | | + | | abbr6 = DRLs |
| + | | list6 = | ||
| + | {{Navbox subgroup | ||
| + | |groupstyle = background:LemonChiffon; | ||
| + | |group1 = [[5-HT1A receptor|5-HT<sub>1A</sub> receptor]] [[Serotonin receptor agonist|agonist]]s | ||
| + | |list1 = <div> | ||
| + | [[Alnespirone]]{{·}} [[Binospirone]]{{·}} [[Buspirone]]{{·}} [[Flesinoxan]]{{·}} [[Flibanserin]]{{·}} [[Gepirone]]{{·}} [[Ipsapirone]]{{·}} [[PRX-00023]]{{·}} [[Tandospirone]]{{·}} [[Zalospirone]] | ||
| + | </div> | ||
| + | |group2 = [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[Serotonin receptor antagonist|antagonist]]s | ||
| + | |list2 = <div> | ||
| + | [[Agomelatine]]{{·}} [[Etoperidone]]{{·}} [[Nefazodone]]{{·}} [[Trazodone]] | ||
| + | </div> | ||
| + | |group3 = [[Corticotropin releasing hormone receptor 1|CRH-1 receptor]] [[Corticotropin releasing hormone antagonist|antagonist]]s | ||
| + | |list3 = <div> | ||
| + | [[Antalarmin]]{{·}} [[CP-154,526]]{{·}} [[Pexacerfont]] | ||
| + | </div> | ||
| + | |group4 = [[Dopamine receptor|D<sub>2</sub>-like autoreceptor]] [[Dopamine receptor antagonist|antagonist]]s | ||
| + | |list4 = <div> | ||
| + | [[Amisulpride]]{{·}} [[Sulpiride]] | ||
| + | </div> | ||
| + | |group5 = [[Dopamine receptor|D<sub>2</sub>-like receptor]] [[Dopamine receptor agonist|agonist]]s | ||
| + | |list5 = <div> | ||
| + | [[Piribedil]]{{·}} [[Pramipexole]]{{·}} [[Ropinirole]]{{·}} [[Rotigotine]] | ||
| + | </div> | ||
| + | |group6 = [[NMDA receptor]] [[NMDA receptor antagonist|antagonist]]s | ||
| + | |list6 = <div> | ||
| + | [[Dextromethorphan]]{{·}} [[Ketamine]] | ||
| + | </div> | ||
| + | |group7 = [[Sigma receptor]] [[agonist]]s | ||
| + | |list7 = <div> | ||
| + | [[Opipramol]] | ||
| + | </div> | ||
| + | }} | ||
| − | | | + | |below = |belowstyle = padding-top:0.2em; |
| − | | | + | |below = {{smallsup|1}} [[List of World Health Organization Essential Medicines|WHO-EM]]{{·}} {{smallsup|2}} [[List of withdrawn drugs|Withdrawn]]{{·}} {{smallsup|3}} [[Clinical trial#Phase III|Clinical trial phase III]]{{·}} {{smallsup|4}} [[Clinical trial#Phase II|Did not reach clinical trial phase III]] |
| + | }}<noinclude> | ||
| + | <br/>{{Collapsible sections option |list="RIs", "SSREs", "NDRAs", "TCAs", "MAOIs" or "DRLs"}} | ||
| − | + | [[Category:Drug templates|{{PAGENAME}}]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
[[fr:Modèle:Antidépresseurs]] | [[fr:Modèle:Antidépresseurs]] | ||
[[hu:Sablon:Antidepresszánsok]] | [[hu:Sablon:Antidepresszánsok]] | ||
[[ru:Шаблон:Антидепрессанты]] | [[ru:Шаблон:Антидепрессанты]] | ||
</noinclude> | </noinclude> | ||
Revision as of 09:41, 1 January 2010
Template:Navbox with collapsible sections
How to manage this template's collapsible groups/sections option
- This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter
|namewhere name is one of the following words that identify the groups/sections (omit any speech or quotation marks): "RIs", "SSREs", "NDRAs", "TCAs", "MAOIs" or "DRLs"
fr:Modèle:Antidépresseurs hu:Sablon:Antidepresszánsok ru:Шаблон:Антидепрессанты